Ampio Pharmaceuticals Inc. [AMEX: AMPE] jumped around 0.11 points on Thursday, while shares priced at $1.72 at the close of the session, up 6.83%. The company report on April 21, 2021 that Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 First Quarter Financial Results and Provide Corporate Business Update.
Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, announced it will host a conference call to discuss financial results for the quarter ended March 31, 2021 and provide a corporate business update on Wednesday, May 5, 2021 at 4:30pm EDT/ 2:30pm MT.
Conference Call & Webcast:.
Ampio Pharmaceuticals Inc. stock is now 8.18% up from its year-to-date (YTD) trading value. AMPE Stock saw the intraday high of $1.74 and lowest of $1.58 per share. The company’s 52-week high price is 2.98, which means current price is +37.60% above from all time high which was touched on 02/12/21.
Compared to the average trading volume of 3.19M shares, AMPE reached a trading volume of 1112433 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Ampio Pharmaceuticals Inc. [AMPE]?
ROTH Capital have made an estimate for Ampio Pharmaceuticals Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 19, 2019. While these analysts kept the previous recommendation, Aegis Capital raised their target price from $15 to $16. The new note on the price target was released on March 17, 2014, representing the official price target for Ampio Pharmaceuticals Inc. stock. Previously, the target price had yet another raise to $11, while Aegis Capital analysts kept a Buy rating on AMPE stock.
The Average True Range (ATR) for Ampio Pharmaceuticals Inc. is set at 0.14 The Price to Book ratio for the last quarter was 19.11, with the Price to Cash per share for the same quarter was set at 0.09.
How has AMPE stock performed recently?
Ampio Pharmaceuticals Inc. [AMPE] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 9.55. With this latest performance, AMPE shares gained by 0.58% in over the last four-week period, additionally plugging by 108.99% over the last 6 months – not to mention a rise of 245.17% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AMPE stock in for the last two-week period is set at 52.13, with the RSI for the last a single of trading hit 55.82, and the three-weeks RSI is set at 50.99 for Ampio Pharmaceuticals Inc. [AMPE]. The present Moving Average for the last 50 days of trading for this stock 1.7572, while it was recorded at 1.6060 for the last single week of trading, and 1.2527 for the last 200 days.
Ampio Pharmaceuticals Inc. [AMPE]: Deeper insight into the fundamentals
Return on Total Capital for AMPE is now -118.91, given the latest momentum, and Return on Invested Capital for the company is -121.84. Return on Equity for this stock declined to -132.70, with Return on Assets sitting at -86.20. When it comes to the capital structure of this company, Ampio Pharmaceuticals Inc. [AMPE] has a Total Debt to Total Equity ratio set at 6.90. Additionally, AMPE Total Debt to Total Capital is recorded at 6.46, with Total Debt to Total Assets ending up at 5.28. Long-Term Debt to Equity for the company is recorded at 5.28, with the Long-Term Debt to Total Capital now at 4.94.
Reflecting on the efficiency of the workforce at the company, Ampio Pharmaceuticals Inc. [AMPE] managed to generate an average of -$883,000 per employee.Ampio Pharmaceuticals Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 10.10 and a Current Ratio set at 10.10.
Earnings analysis for Ampio Pharmaceuticals Inc. [AMPE]
With the latest financial reports released by the company, Ampio Pharmaceuticals Inc. posted -0.01/share EPS, while the average EPS was predicted by analysts to be reported at -0.03/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 66.70%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AMPE.
Insider trade positions for Ampio Pharmaceuticals Inc. [AMPE]
There are presently around $43 million, or 14.80% of AMPE stock, in the hands of institutional investors. The top three institutional holders of AMPE stocks are: VANGUARD GROUP INC with ownership of 7,078,725, which is approximately 17.976% of the company’s market cap and around 0.40% of the total institutional ownership; BLACKROCK INC., holding 3,104,227 shares of the stock with an approximate value of $5.34 million in AMPE stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $2.13 million in AMPE stock with ownership of nearly 37.827% of the company’s market capitalization.
Positions in Ampio Pharmaceuticals Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 57 institutional holders increased their position in Ampio Pharmaceuticals Inc. [AMEX:AMPE] by around 6,412,228 shares. Additionally, 20 investors decreased positions by around 451,405 shares, while 31 investors held positions by with 18,368,001 shares. The mentioned changes placed institutional holdings at 25,231,634 shares, according to the latest SEC report filing. AMPE stock had 28 new institutional investments in for a total of 2,205,890 shares, while 8 institutional investors sold positions of 192,230 shares during the same period.